CSE:ACOG - Post Discussion
Post by
partystocker on Feb 10, 2022 5:43pm
$ACOG Shares Approaching Pivotal Price Range
Now is the time to set alerts for any announcements from Alpha Cognition (ACOG:TSVX). The company’s shares have been continuing on a downward trend towards established support of $.92 for almost 4 months.
With volume continuing to trend downwards as well, shares are reaching a pivotal moment as price action approaches the intersection of the trend and support lines. The right announcement from $ACOG regarding its ALPHA-1062 prodrug in development could send shares on a breakaway if delivered at the right time in the next two weeks.
The current estimated healthcare cost for Alzheimer’s and other dementias is $355 billion per year and is expected to increase to more than $1.1 trillion by 2059. $ACOG’s ALPHA-1062 pro-drug presents a massive opportunity, as it has a much lower side effect profile than current Alzheimer’s treatments. This means patients can be ramped up to a therapeutic dose, and reap the benefits thereof much faster.
$ACOG is currently trading at $1.0 and the company is valued at an MCAP of $61.5 million.
Be the first to comment on this post